Abbvie Inc Drug Patent Portfolio

Drug Patent Number Drug Patent Title Drug Patent Expiry Status


Abbvie Inc's Family Patents


Family Patents



Abbvie Inc Drug List

Given below is the complete list of Abbvie Inc's drugs and the patents protecting them.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

FDA's Initiative to Lower Drug Prices Through Biosimilar Strategy Relies on Additional Reforms - Bloomberg Law News

09 Dec, 2025

Assessing the Strength of AbbVie's Immunology Division Following Humira's Loss of Exclusivity - The Globe and Mail

04 Dec, 2025

AbbVie Receives Canadian Approval Recommendations for Major Ulcerative Colitis Treatment

28 Nov, 2025

Protein Pharmaceuticals Market: Revolutionizing Healthcare through Innovation and Strategic Partnerships

18 Nov, 2025

See More